drugset / Trial / NCT02492503
Effectiveness of Chemotherapy in Metastatic or Recurrent Carcinoma Cervix
RandomizedParallel-groupOpen-labelTreatment
Summary
Experience with substituting carboplatin for cisplatin is limited in advanced and recurrent cervix cancer and there has been no counterpart to GOG 158, which documented therapeutic equivalency of cisplatin/paclitaxel and carboplatin/paclitaxel for treatment of ovarian cancer, performed in a cervix cancer population.
Timeline
- Start
- 2013-11
- Primary completion
- 2015-08
- Completion
- 2015-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Carboplatin | Small molecule | 2 unknown | — |
| Comparator | Carboplatin | Small molecule | 4 unknown | — |
| Comparator | Carboplatin | Small molecule | 5 unknown | — |
| Comparator | Paclitaxel | Small molecule | 60 mg/m2 | — |
| Comparator | Paclitaxel | Small molecule | 175 mg/m2 | — |